Draft:De Novo Drug Design Algorithms
 | This is a draft article. It is a work in progress open to editing by anyone. Please ensure core content policies are met before publishing it as a live Wikipedia article. Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL Last edited by CycloneYoris (talk | contribs) 2 seconds ago. (Update)
Finished drafting? or |
 |
De novo drug design is a specialized approach within drug discovery, focusing on the creation of molecular structures with drug-like properties that are distinct from existing therapeutic agents. Unlike traditional drug development, which iteratively modifies known molecules, de novo methods generate novel structures from scratch, leveraging either rational or random approaches.
This technique often utilizes detailed information about the target structure and known binders to generate new patterns of binding.
List of Algorithms
[edit]The table below provides a list of algorithms designed for de novo drug design.
| Article Name | DOI | Publication Date |
|---|---|---|
| LigBuilder | 10.1007/S0089400060498 | 2000-08-01 |
| LigBuilder2 | 10.1021/CI100350U | 2011-05-03 |
| LigBuilder3 | 10.3389/FCHEM.2020.00142 | 2020-02-28 |
| Popova-Tropsha | 10.1126/SCIADV.AAP7885 | 2018-07 |
| LigDream | 10.1021/ACS.JCIM.8B00706 | 2019-02-28 |
| MEGA | 10.1186/1752-153X-3-S1-P22 | 2009 |
| GroupBuild | 10.1021/JM00064A003 | 1993-06-01 |
| Li-Liu | 10.1186/S13321-018-0287-6 | 2018-07-24 |
| MoGADdrug | 10.2174/1573409916666200620194143 | 2020-06-20 |
| Polykovskiy-Kadurin | 10.1021/ACS.MOLPHARMACEUT.8B00839 | 2018-09-19 |
| Ligand | 10.1063/1.47765 | 1995 |
| DeepScaffold | 10.1021/ACS.JCIM.9B00727 | 2019-12-20 |
| reinvent-scaffold-decorator | 10.26434/CHEMRXIV.11638383 | 2020-01-21 |
| GenStar | 10.1007/BF00141573 | 1993-02-01 |
| REINVENT 2.0 | 10.1021/ACS.JCIM.0C00915 | 2020-10-29 |
| Masek | 10.1021/ACS.JCIM.5B00697 | 2016-03-31 |
| moo-denovo | 10.1021/ACS.JCIM.0C00517 | 2020-08-26 |
See also
[edit]